• 검색 결과가 없습니다.

Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?

N/A
N/A
Protected

Academic year: 2021

Share "Is tenofovir and entecavir combination therapy still the optimal treatment for chronic hepatitis B patients with prior suboptimal response?"

Copied!
3
0
0

로드 중.... (전체 텍스트 보기)

전체 글

Loading

수치

Table 1. Summary of anti-viral efficacy results of tenofovir-based therapy in patients with suboptimal response or resistance to NAs Study Study design Study population Intervention Primary efficacy end

참조

관련 문서

Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind,

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)..

(Background) The standard triple therapy used as the first-line treatment for Helicobacter pylori infection are a combination of proton pump inhibitor(PPI),

Intermittent hemodialysis(IDH) and Continuous renal replacement therapy (CRRT) has been used widely for treating critically ill patients with acute renal failure, We

Median overall survival of 28 multiple myeloma patients treated with Cyclophosphamide-Prednisone combination regimens as a primary therapy was 115 weeks.. Median

The aim of this study was to provide a optimal drug therapy which secures effectiveness and safeness in elderly patients by analyzing polypharmacy and the

Full genome cloning and nucleotide sequence analysis of hepatitis C virus from sera of chronic hepatitis patients in Korea. Detection of hepatitis C virus RNA

Baseline characteristics of genotype 1b chronic hepatitis C patients who treated with daclatasvir and asunaprevir (n=231)... Characteristics of genotype 1b